Donald A. Clarke - Concepedia

Concepedia

Author

Donald A. Clarke

Kettering University

Also Known As

D A CLARKE, D A Clarke, D. A. CLARKE, D. A. Clarke, D.A. Clarke, DONALD A. CLARKE, Donald A. Clarke, Donald Clarke, F S PHILIPS

49

Publications

2.5K

Citations

21

H-Index

72

Concepts

All Affiliations

Kettering University Cornell University New York University

DA

About

Donald A. Clarke is an author at Kettering University specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	2.2K
2	Health Sciences	3	3	142
3	Natural Sciences	2	2	129
4	Education	1	1	19
5	Engineering	1	1	73

Donald A. Clarke

×

26

Publications

2.5K

Citations

20

H-Index

	Year	Citations
Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse Lloyd J. Old, Donald A. Clarke, Baruj Benacerraf Nature XenotransplantationPathogenesisImmunologyPathologyBacillus Calmette-guérin Infection	1959	524
ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS* Lloyd J. Old, Edward A. Boyse, Donald A. Clarke, Annals of the New York Academy of Sciences Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityImmunoediting	1962	523
THE RETICULOENDOTHELIAL SYSTEM AND THE NEOPLASTIC PROCESS* Lloyd J. Old, Donald A. Clarke, Baruj Benacerraf, Annals of the New York Academy of Sciences AngiogenesisVascular AdaptationHistopathologyPathologyVascular Biology	1960	170
6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals. Donald A. Clarke, Frederick S. Philips, Stephen S. Sternberg, PubMed Experimental Mouse TumorMalignant DiseaseMedicineImmunologyTherapeutic Efficacy	1953	141
THE TOXIC EFFECTS OF 6‐MERCAPTOPURINE AND RELATED COMPOUNDS Frederick S. Philips, Stephen S. Sternberg, Leonard Hamilton, Annals of the New York Academy of Sciences MedicineChemical HazardToxicologyAnd Related CompoundsToxicological Aspect	1954	123
Azaserine, A New Tumour-Inhibitory Substance: Studies with Crocker Mouse Sarcoma 180 Christiane Stock, H. Christine Reilly, Sonja M. Buckley, Nature Tumoral PathologyOncogenic AgentMedicinePharmacologyCancer Cell Biology	1954	97
Stimulation of host defense against experimental cancer. I. Zymosan and sarcoma 180 in mice. William T. Bradner, Donald A. Clarke, Christiane Stock PubMed I. ZymosanImmunologyImmune RegulationPathologyImmunoediting	1958	95
ENZYMATIC DEAMINATION AND VASODEPRESSOR EFFECTS OF ADENOSINE ANALOGS Donald A. Clarke, John Davoll, Frederick S. Philips, Journal of Pharmacology and Experimental Therapeutics	1952	92
Tumor inhibitors in Boletus edulis and other Holobasidiomycetes. Richard U. Byerrum, Donald A. Clarke, E. Herrero-De Lucas, PubMed MedicinePathologyAnti-cancer AgentTumor InhibitorsPharmacology	1957	89
A HISTOCHEMICAL STUDY OF ACID AND ALKALINE PHOSPHATASE IN MOUSE LIVERS DURING VARIOUS CONDITIONS MODIFYING ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM G. J. Thorbecke, Lloyd J. Old, Baruj Benacerraf, Journal of Histochemistry & Cytochemistry Lipid PeroxidationPathologyCellular PhysiologyRedox BiologyOxidative Stress	1961	87

Page 1